As of 2025-05-26, the Relative Valuation of GlaxoSmithKline PLC (GSK.L) is 1,575.93 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 1,425.50 GBP, the upside of GlaxoSmithKline PLC based on Relative Valuation is 10.6%.
The range of the Relative Valuation is 1,466.62 - 1,747.32 GBP.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 21.9x | 19.6x |
| Forward P/E multiples | 19.5x - 22.8x | 21.2x |
| Fair Price | 1,466.62 - 1,747.32 | 1,575.93 |
| Upside | 2.9% - 22.6% | 10.6% |
| Date | P/E |
| 2025-05-23 | 18.31 |
| 2025-05-22 | 18.35 |
| 2025-05-21 | 18.37 |
| 2025-05-20 | 18.18 |
| 2025-05-19 | 17.94 |
| 2025-05-16 | 17.91 |
| 2025-05-15 | 17.50 |
| 2025-05-14 | 17.47 |
| 2025-05-13 | 17.44 |
| 2025-05-12 | 17.98 |
| 2025-05-09 | 17.70 |
| 2025-05-08 | 17.52 |
| 2025-05-07 | 17.71 |
| 2025-05-06 | 18.63 |
| 2025-05-02 | 18.61 |
| 2025-05-01 | 18.79 |
| 2025-04-30 | 19.06 |
| 2025-04-29 | 18.40 |
| 2025-04-28 | 18.10 |
| 2025-04-25 | 17.84 |
| 2025-04-24 | 17.91 |
| 2025-04-23 | 17.71 |
| 2025-04-22 | 17.50 |
| 2025-04-17 | 17.17 |
| 2025-04-16 | 17.28 |
| 2025-04-15 | 17.29 |
| 2025-04-14 | 16.99 |
| 2025-04-11 | 16.62 |
| 2025-04-10 | 16.38 |
| 2025-04-09 | 16.24 |
| 2025-04-08 | 17.22 |
| 2025-04-07 | 17.10 |
| 2025-04-04 | 18.21 |
| 2025-04-03 | 18.83 |
| 2025-04-02 | 18.41 |
| 2025-04-01 | 18.87 |
| 2025-03-31 | 18.78 |
| 2025-03-28 | 19.12 |
| 2025-03-27 | 18.98 |
| 2025-03-26 | 18.95 |
| 2025-03-25 | 19.09 |
| 2025-03-24 | 19.08 |
| 2025-03-21 | 19.38 |
| 2025-03-20 | 19.41 |
| 2025-03-19 | 19.33 |
| 2025-03-18 | 19.67 |
| 2025-03-17 | 19.73 |
| 2025-03-14 | 19.41 |
| 2025-03-13 | 19.26 |
| 2025-03-12 | 19.14 |